Advertisement

Cellular and Molecular Neurobiology

, Volume 28, Issue 2, pp 307–316 | Cite as

Carnosine Protects Against Aβ42-induced Neurotoxicity in Differentiated Rat PC12 Cells

  • Qiuli Fu
  • Haibin Dai
  • Weiwei Hu
  • Yanying Fan
  • Yao Shen
  • Weiping Zhang
  • Zhong ChenEmail author
Original Paper

Abstract

(1) The present study was designed to investigate whether histamine is involved in the protective effect of carnosine on Aβ42-induced impairment in differentiated PC12 cells. (2) PC12 cells were exposed to Aβ42 (5 μM) for 24 h after carnosine (5 mM) applied for 18 h. Histamine receptor antagonists (diphenhydramine, zolantidine, thioperamide, clobenpropit) or histidine decarboxylase inhibitor (α-fluoromethylhistidine) were added 15 min before carnosine. Cell viability, glutamate release or cell surface expression of NMDA receptor was examined. (3) Aβ42 caused a concentration-dependent reduction of viability in PC12 cells and pretreatment with carnosine ameliorated this impairment. This amelioration was reversed by the H3 receptor antagonists thioperamide and clobenpropit, but not by either the H1 receptor antagonist diphenhydramine or the H2 receptor antagonist zolantidine. Further, α-fluoromethylhistidine, an irreversible inhibitor of histidine decarboxylase, also had no effect. In the presence of Aβ42, carnosine significantly decreased glutamate release and carnosine increased the surface expression of NMDA receptor. (4) These results indicate that the mechanism by which carnosine attenuates Aβ42-induced neurotoxicity is independent of the carnosine–histidine–histamine pathway, but may act through regulation of glutamate release and NMDA receptor trafficking.

Keywords

Carnosine Alzheimer’s disease Histamine Aβ42 NMDA receptor Trafficking Neurotoxicity 

Notes

Acknowledgments

This project was supported by grants from the National Natural Science Foundation of China (30725047,30572176 and 30600757) and New Century Excellent Talents Program, Ministry of Education, China (NCET-06-0511) and partly by the Zhejiang Province Healthy Excellent Youth Foundation. We are very grateful to Dr. Iain C. Bruce for reading the manuscript.

References

  1. Airaksinen MS, Paetau A, Paljarvi L, Reinikainen K, Riekkinen P, Suomalainen R, Panula P (1991) Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience 44(2):465–481PubMedCrossRefGoogle Scholar
  2. Bonfanti L, Peretto P, De Marchis S, Fasolo A (1999) Carnosine related dipeptides in the mammalian brain. Prog Neurobiol 59(4):333–353PubMedCrossRefGoogle Scholar
  3. Carmosino M, Procino G, Nicchia GP, Mannucci R, Verbavatz JM, Gobin R, Svelto M, Valenti G (2001) Histamine treatment induces rearrangements of orthogonal arrays of particles (OAPs) in human AQP4-expressing gastric cells. J Cell Biol 154(6):1235–1243PubMedCrossRefGoogle Scholar
  4. Dai H, Zhang Z, Zhu Y, Shen Y, Hu W, Huang Y, Luo J, Timmerman H, Leurs R, Chen Z (2006) Histamine protects against NMDA-induced necrosis in cultured cortical neurons through H2 receptor/cyclic AMP/protein kinase A and H3 receptor/GABA release pathways. J Neurochem 96(5):1390–1400PubMedCrossRefGoogle Scholar
  5. Doble A (1999) The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 81(3):163–221PubMedCrossRefGoogle Scholar
  6. Donzanti BA, Yamamoto BK (1988) An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sci 43(11):913–922PubMedCrossRefGoogle Scholar
  7. Flancbaum L, Fitzpatrick JC, Brotman DN, Marcoux AM, Kasziba E, Fisher H (1990) The presence and significance of carnosine in histamine-containing tissues of several mammalian species. Agents Actions 31(3–4):190–196PubMedCrossRefGoogle Scholar
  8. Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG (2007) Free amino acid and dipeptide changes in the body fluids from Alzheimer’s disease subjects. Amino Acids 32(2):213–224PubMedCrossRefGoogle Scholar
  9. Fu Q, Dai H, Shen Y (2007) Reversing effect of histamine on neurotoxicity induced by β-amyloid1–42. J Zhejiang Univ Med Sci 36(2):146–149Google Scholar
  10. Haas H, Panula P (2003) The role of histamine and the tuberomammillary nucleus in the nervous system. Nat Rev Neurosci 4(2):121–130PubMedCrossRefGoogle Scholar
  11. Hardy J, Duff K, Hardy KG, Perez-Tur J, Hutton M (1998) Genetic dissection of Alzheimer’s disease and related dementias: amyloid and its relationship to tau. Nat Neurosci 1(5):355–358PubMedCrossRefGoogle Scholar
  12. Hipkiss AR (1998) Carnosine, a protective, anti-ageing peptide? Int J Biochem Cell Biol 30(8):863–868PubMedCrossRefGoogle Scholar
  13. Hobart LJ, Seibel I, Yeargans GS, Seidler NW (2004) Anti-crosslinking properties of carnosine: significance of histidine. Life Sci 75(11):1379–1389PubMedCrossRefGoogle Scholar
  14. Jin CL, Yang LX, Wu XH, Li Q, Ding MP, Fan YY, Zhang WP, Luo JH, Chen Z (2005) Effects of carnosine on amygdaloid-kindled seizures in Sprague-Dawley rats. Neuroscience 135(3):939–947PubMedCrossRefGoogle Scholar
  15. Kasziba E, Flancbaum L, Fitzpatrick JC, Schneiderman J, Fisher H (1988) Simultaneous determination of histidine-containing dipeptides, histamine, methylhistamine and histidine by high-performance liquid chromatography. J Chromatogr 432:315–320PubMedCrossRefGoogle Scholar
  16. McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, Skipper L, Murphy MP, Beard J, Das P, Jansen K, DeLucia M, Lin, WL, Dolios, G, Wang, R, Eckman, CB, Dickson, DW, Eckman, CB, Dickson, DW (2005) Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47(2):191–199PubMedCrossRefGoogle Scholar
  17. Nong Y, Huang YQ, Ju W, Kalia LV, Ahmadian G, Wang YT, Salter MW (2003) Glycine binding primes NMDA receptor internalization. Nature 422(6929):302–307PubMedCrossRefGoogle Scholar
  18. Pannaccione A, Secondo A, Scorziello A, Cali G, Taglialatela M, Annunziato L (2005) Nuclear factor-kappaB activation by reactive oxygen species mediates voltage-gated K+ current enhancement by neurotoxic beta-amyloid peptides in nerve growth factor-differentiated PC-12 cells and hippocampal neurones. J Neurochem 94(3):572–586PubMedCrossRefGoogle Scholar
  19. Panula P, Rinne J, Kuokkanen K, Eriksson KS, Sallmen T, Kalimo H, Relja M (1998) Neuronal histamine deficit in Alzheimer’s disease. Neuroscience 82(4):993–997PubMedCrossRefGoogle Scholar
  20. Passani MB, Bacciottini L, Mannaioni PF, Blandina P (2000) Central histaminergic system and cognition. Neurosci Biobehav Rev 24(1):107–113PubMedCrossRefGoogle Scholar
  21. Prestona JE, Hipkiss AR, Himsworth DT, Romero IA, Abbott JN (1998) Toxic effects of beta-amyloid(25–35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine. Neurosci Lett 242(2):105–108CrossRefGoogle Scholar
  22. Schwartz JC, Arrang JM, Garabarg M, Pollard H, Ruat M (1991) Histaminergic transmission in the mammalian brain. Physiol Rev 71(1):1–51PubMedGoogle Scholar
  23. Sharpan IuV (1984) Influence of carnosine on the immunosuppressive effect of histamine. Biull Eksp Biol Med 98(11):603–604PubMedGoogle Scholar
  24. Shen Y, Hu WW, Fan YY, Dai HB, Fu QL, Wei EQ, Luo JH, Chen Z (2007) Carnosine protects against NMDA-induced neurotoxicity in differentiated rat PC12 cells through carnosine-histidine-histamine pathway and H(1)/H(3) receptors. Biochem Pharmacol 73(5):709–717PubMedCrossRefGoogle Scholar
  25. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8(8):1051–1058PubMedCrossRefGoogle Scholar
  26. Tanzi PE, Bertram L (2005) Twenty years of the Alzheimer’s review disease amyloid hypothesis: a genetic perspective. Cell 120(4):545–555PubMedCrossRefGoogle Scholar
  27. Trombley PQ, Horning MS, Blakemore LJ (1998) Carnosine modulates zinc and copper effects on amino acid receptors and synaptic transmission. Neuroreport 9(15):3503–3507PubMedCrossRefGoogle Scholar
  28. Trombley PQ, Horning MS, Blakemore LJ (2000) Interactions between carnosine and zinc and copper: implications for neuromodulation and neuroprotection. Biochemistry (Mosc) 65(7):807–816Google Scholar
  29. Walton HS, Dodd PR (2006) Glutamate–glutamine cycling in Alzheimer’s disease. Neurochem Int 50:1052–1066Google Scholar
  30. Wu X, Ding M, Zhu-Ge Z, Zhu Y, Jin C, Chen Z (2006) Carnosine, a precursor of histidine, ameliorates pentylenetetrazole-induced kindled seizures in rat. Neurosci Lett 400(1–2):146–149PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Qiuli Fu
    • 1
  • Haibin Dai
    • 1
    • 2
  • Weiwei Hu
    • 1
  • Yanying Fan
    • 1
  • Yao Shen
    • 1
  • Weiping Zhang
    • 1
  • Zhong Chen
    • 1
    Email author
  1. 1.Department of Pharmacology, Institute of Neuroscience, School of MedicineZhejiang UniversityHangzhouChina
  2. 2.Department of Pharmacy, Second Affiliated Hospital, School of MedicineZhejiang UniversityHangzhouChina

Personalised recommendations